Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?
Asthma is a widespread disease characterized by chronic airway inflammation. It causes substantial disability, impaired quality of life, and avoidable deaths around the world. The main treatment for asthmatic patients is the administration of corticosteroids, which improves the quality of life; howe...
Main Authors: | Andressa Daronco Cereta, Vinícius Rosa Oliveira, Ivan Peres Costa, João Pedro Ribeiro Afonso, Adriano Luís Fonseca, Alan Robson Trigueiro de Souza, Guilherme Augusto Moreira Silva, Diego A. C. P. G. Mello, Luis Vicente Franco de Oliveira, Renata Kelly da Palma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.648506/full |
Similar Items
-
Early Life Microbial Exposure and Immunity Training Effects on Asthma Development and Progression
by: Andressa Daronco Cereta, et al.
Published: (2021-06-01) -
Photobiomodulation Therapy Restores IL-10 Secretion in a Murine Model of Chronic Asthma: Relevance to the Population of CD4+CD25+Foxp3+ Cells in Lung
by: Aurileia Aparecida de Brito, et al.
Published: (2022-02-01) -
Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma
by: Ligia Lins de Castro, et al.
Published: (2017-06-01) -
Editorial: Unraveling the physiology of cells and extracellular matrix: Techniques for biochemical and biophysical characterization
by: Renata Kelly Da Palma, et al.
Published: (2023-01-01) -
Alveolus Lung-on-a-Chip Platform: A Proposal
by: Noelia Campillo, et al.
Published: (2021-09-01)